In glioblastoma cells harboring the TERT promoter mutation, GABPB1 depletion led to reduced TERT expression coupled with diminished telomerase activity followed by progressive telomere attrition and eventual loss of oncogenic potential [17]. This evidence concerns the gene GABPB1 and glioblastoma.